Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 537

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial Infarction

Gibson, Robert S., Boden, William E., Theroux, Pierre, Strauss, Hans D., Pratt, Craig M., Gheorghiade, Mihai, Capone, Robert J., Crawford, Michael H., Schlant, Robert C., Kleiger, Robert E., Young, Phillip M., Schechtman, Kenneth, Perryman, M. Benjamin, Roberts, Robert, the Diltiazem Reinfarction Study Group·1986·New England Journal of Medicine

Abstract

We performed a multicenter, double-blind, randomized study to evaluate the effect of diltiazem on reinfarction after a non-Q-wave myocardial infarction. Nine centers enrolled 576 patients: 287 received diltiazem (90 mg every six hours) and 289 received placebo. Treatment was initiated 24 to 72 hours after the onset of infarction and continued for up to 14 days. The primary end point, reinfarction, was defined as an abnormal reelevation of MB creatine kinase in plasma within 14 days. Reinfarction occurred in 27 patients in the placebo group (9.3 percent) and in 15 in the diltiazem group (5.2 percent)--a 51.2 percent reduction in cumulative life-table incidence (P = 0.0297; 90 percent confidence interval, 7 to 67 percent). Diltiazem reduced the frequency of refractory postinfarction angina (a secondary end point) by 49.7 percent (P = 0.0345; 90 percent confidence interval, 6 to 73 percent). Mortality was similar in the two groups (3.1 and 3.8 percent, respectively, in the placebo and diltiazem groups), but adverse drug reactions (most of which were mild) were more common in the diltiazem group. Nevertheless, the drug was well tolerated, despite concurrent treatment with beta-blockers in 61 percent of the patients. We conclude that diltiazem was effective in preventing early reinfarction and severe angina after non-Q-wave infarction and that it was also safe and generally well tolerated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm198608143150704

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 537

Metadata

Authors
Gibson, R. S., Boden, W. E., Theroux, P., Strauss, H. D., Pratt, C. M., Gheorghiade, M., Capone, R. J., Crawford, M. H., Schlant, R. C., Kleiger, R. E., Young, P. M., Schechtman, K., Perryman, M. B., Roberts, R., & the Diltiazem Reinfarction Study Group
Venue
New England Journal of Medicine
Published
1986-08-14
Volume
315
Issue
7
Pages
423-429
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2322661993
Cited by
537
References
24
FWCI
44.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial Infarction. https://app.cochat.ai/papers/10.1056/nejm198608143150704
The paper
Gibson, R. S., Boden, W. E., Theroux, P., Strauss, H. D., Pratt, C. M., Gheorghiade, M., Capone, R. J., Crawford, M. H., Schlant, R. C., Kleiger, R. E., Young, P. M., Schechtman, K., Perryman, M. B., Roberts, R., & the Diltiazem Reinfarction Study Group. (1986). Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial Infarction. New England Journal of Medicine. https://doi.org/10.1056/nejm198608143150704

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.